Caricamento...
Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations
BACKGROUND: Robenacoxib is a non-steroidal anti-inflammatory drug available for canine and feline use for the control of pain and inflammation marketed as Onsior™. The aim of this target animal safety study was to evaluate the 6-month safety profile of oral robenacoxib administration. It was a rando...
Salvato in:
| Pubblicato in: | BMC Vet Res |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6098579/ https://ncbi.nlm.nih.gov/pubmed/30119677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-018-1566-1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|